A Comparison of Safety and Efficacy of Dl-3-n-butylphthalide and Cerebrolysin on Neurological and Behavioral Outcomes in Acute Ischemic Stroke: a Randomized, Double-blind Study.
Phase of Trial: Phase I/II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Brain extract (Primary) ; Butylphthalide (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 04 Jul 2014 New trial record